Cancer Management Practices during the Novel Coronavirus Disease 2019 ( COVID-19 ) Pandemic

The COVID-19 pandemic has significantly impacted the management, treatment, and delivery of care to cancer patients. This impact has extended beyond patient care to include logistics, administration, and distribution of increasingly limited health care resources in cancer management healthcare institutions. Based on the collaborative experience of the management, administration, and medical staff at AL-Amal National Hospital (a tertiary health care institution delivering cancer management and treatment services in Baghdad, Iraq), measures were taken and recommendations were carefully formulated to safely proceed with therapy for cancer patients amid the current COVID-19 Pandemic. We hereby review and present AL-Amal National Hospital’s urgent plan to ensure that vital cancer services can still be delivered safely taking into consideration all the potential risks and benefits during this pandemic.


Introduction
The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO) [1]. The newly identified coronavirus, also known as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-tohuman transmission [2]. It causes mild to moderate symptoms in most patients, who recover within a few weeks [3], but it is highly contagious and can cause severe illness or death, particularly in older patients or those with compromised immune systems, including cancer patients. For them, Covid-19 can be much more severe and more likely to be fatal. [4,5]. According to a special March 17 Page: 23 www.raftpubs.com preprint report from the National Comprehensive Cancer Network, early reports out of China show that patients with cancer infected with Covid-19 have a 3.5 times higher chance of mechanical ventilation, ICU admission, or death compared with patients without cancer . As such, there is an urgent need to address the impact of such a pandemic on cancer patients. This includes changes in resource allocation, clinical care, and treatment options during this pandemic [6]. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. Therefore delivering cancer care during this crisis is challenging given the competing risks of death from cancer versus death or serious complications from SARS-CoV-2 in immunocompromised patients [7,8]. Many cancer patients are struggling to receive treatment due to hospitals canceling or delaying cancer management processes like chemotherapy and radiation therapy, surgeries, and other procedures. Moreover, patients with curable cancers that require timely implementation of surgery, chemotherapy, or radiation have regrettably concluded that the risk of contracting COVID-19 may be greater than the benefits of cancer treatment [9]. This rapidly expanding COVID-19 pandemic has impacted all areas of daily life, including medical care. Inadequate supplies of personal protective equipment (PPE) for health care providers, limited hospital capacity, including intensive care units (ICUs), and lack of point-of-care testing (POCT) further complicate the situation and increase the difficulty of cancer management [10]. Oncologists are acutely aware of the risks of their immunocompromised patients contracting Covid-19, but they are also aware that stopping or canceling chemotherapy, for many patients, could present more life threats. For all that, different measures are taken by different health care institutions to change and amend the management practices at their facilities. In this review we summarize the experience of AL -Amal hospital (a tertiary health care institution delivering cancer management and treatment services in Baghdad, Iraq) in facing the potential challenges associated with managing its cancer patients during the COVID-19 pandemic, with suggestions of some approaches and management decisions to ensure the safe continuity of care at this hospital. Page: 24 www.raftpubs.com

Patient load and normal daily workflow before Coronavirus pandemic
In the pre COVID-19 period admissions to the hospital counted to around 5000 to 6000 visits per week distributed as follows : +/-300 patients/day (oncology clinics) , 200-250 patients/ day (nuclear medicine departement), 150 patients/day (radiology department), 120 patients/day ( Radiotherapy), 250-350 Lab tests /day, based on a 5 days per week schedule. As for the patient admission procedure prior to COVID-19 period, the 14 outpatient clinics welcome the patients on daily basis, those who need chemotherapy are presented to a scientific committee to discuss the case and agree upon the protocols to be administered which are then recorded at a check desk. The treating oncologist admits the patient to the ward and the clinical pharmacist dispenses the medication where the nursing staff monitors the treatment delivery along with the resident doctors. If the patient needs radiotherapy, he or she is referred to CT simulation under direct supervision of the treating clinical oncologist who then starts contouring the tumor as per the international guidelines & writes the prescription dose. The final treatment plan is approved by the oncologist.
The patient undergoes the radiotherapy treatment session under the supervision of the radiotherapy technicians and its monitored by his oncologist every 5 fractions. Finally the patient's health record is updated and the treatment plans, tests, reports, and the appointment of the next treatment session or next follow-up visit are all updated there. Under normal circumstances prior to the COVOD-19 Pandemic, the hospital always ensured managing patients as per their normal protocols without delay in any treatments or follow-up tests required.

Coronavirus challenges and changes in managerial / medical practices during the COVID-19 pandemic.
As COVID 19 hit Iraq, AL-Amal National Hospital management started preparing for worst case scenarios. It was mandatory to implement a comprehensive list of preventive actions, to adjust the level of awareness and alertness among patients and healthcare staff, to secure adequate personal protective equipment (PPE) for health care workers, and to apply infection prevention and control measures at all the hospital levels and departments. The main aim of the hospital management was to issue recommendations for oncology practices to keep cancer patients, as well as their caregivers and health care staff, as safe as possible during the COVID-19 pandemic. In light of this challenging situation, protection and prevention measures for safe cancer management and administration of anticancer therapy were taken at the hospital at many levels: at the daily hospital infection control level, at the daily workflow process level and at the patient cancer management level.

The daily hospital infection control measures
Planning for an emerging infectious disease pandemic, like COVID-19, is critical to protecting the health and welfare of cancer patients under treatment, as well as the healthcare staff who are on the frontline facing this pandemic [11,12] AL-Amal National Hospital management developed a strategy to manage their space, staff, and supplies so that optimum safety and care is provided to the patients. In addition, a set of infection prevention measures and activities listed below were implemented to prepare for, respond to, and be resilient in the face of COVID-19.

The daily inpatient/ outpatient/ visitor workflow process
Patients undergoing cancer care counseling, active treatment, and surveillance are highly exposed to medical centers, care providers, staff, and other patients. This results in a huge number of personal contact points and a large number of potential opportunities for viral transmission among both patients and caregivers [6,[13][14][15][16][17]  Page: 26 www.raftpubs.com

The patient cancer management process
Anti-cancer treatments such as chemotherapy can weaken the immune system, and potentially put patients at greater risk to Covid-19 particularly if they recently received or are continuing to receive treatment [18,19]. During these exceptional circumstances, difficult decisions about how and when to provide cancer treatment have become a necessity. Treatment decisions taken must balance the risk of cancer progression with delay of cancer care versus the risk for significant morbidity from COVID-19 [20]. Hospitals are making these decisions "on a case by case basis". There is no single international standard that can be applied. Nevertheless, individual treatment decisions should consider factors such as the stage of the cancer, the specific type of chemotherapy they're receiving, and the risk of cancer recurrence if treatment should be delayed [6]. Accordingly, AL-Amal Hospital management, oncologists, nurses, care teams, and hospital administrators have been working to address each patient treatment plan individually taking into consideration the following: the likelihood of cure or extension of life from the cancer treatments, the potential risks of delaying treatment, and the local incidence of coronavirus. Practical considerations listed below were taken by the hospital for safe administration of anticancer therapy in light of these disruptions. It is important to mention that these adjusting treatment plans were followed according to international cancer management guidelines.

Conclusion
In this review, we summarized the current challenges faced and the changes implemented in managing cancer patients during the COVID-19 pandemic at AL -Amal Hospital for cancer management in Baghdad, Iraq. Protection and prevention measures for safe cancer management were taken at many levels: the facility level, the daily workflow process level and at the cancer patient treatment level in order to minimize the risk of Coronavirus infection spread among healthcare staff and patients. This approach proved its success at this hospital so far in terms of smoothly managing cancer patients and not recording any infected cases.